All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 2: Cardiovascular
Toggle Pages
Print this page
Management of atrial fibrillation
Drugs that prolong the QT interval
Anticoagulation prescribing guidance
Management of suspected deep vein thrombosis (DVT) and pulmonary embolism (PE)
Secondary prevention of stroke / TIA in primary care
Management of angina
Chronic heart failure guidance
Management of hypertension
Management of blood lipids
2.1 Positive inotropic drugs
2.2 Diuretics
2.3 Anti-arrhythmic drugs
2.4 Beta-adrenoceptor blocking drugs
2.5 Hypertension and heart failure
2.6 Nitrates, calcium-channel blockers, and other antianginal drugs
2.7 Sympathomimetics
2.8 Anticoagulants and protamine
2.9 Antiplatelet drugs
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
2.11 Antifibrinolytic drugs and haemostatics
2.12 Lipid regulating drugs
2.13 Local sclerosants
2.14 Miscellaneous cardiovascular preparations
Contact us about this page
2.10 Stable angina, acute coronary syndromes, and fibrinolysis
First Line
Second Line
Specialist
Hospital Only
2.10.2 Fibrinolytic drugs
NICE TA52 on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (October 2002)
Streptokinase
- Injection 1.5 million units
Alteplase (rt-PA)
- Vial 10mg, 20mg, 50mg
Notes
- NICE TA264 Alteplase for treating acute ischaemic stroke (September 2012)
Tenecteplase
- Powder and solvent for solution for injection vial 5,000units, 8,000units, 10,000units
Notes
- NICE TA990: Tenecteplase (Metalyse) is recommended, within its marketing authorisation, as an option for the thrombolytic treatment of an acute ischaemic stroke in adults (July 2024):
- within 4.5 hours of the onset of stroke symptoms, and
- when intracranial haemorrhage has been excluded.
